MTI Signs Multi-Million Dollar Licensing Agreement

There were fist bumps and high-fives around Metabolomic Technologies Inc’s (MTI) office, and by early May, 2016, all was official and announced.

MTI had made its first major sale. The long-time TEC Edmonton client has signed a multi-million-dollar licensing and distribution agreement with Pennsylvania-based Atlantic Diagnostic Laboratories (ADL).

ADL will be selling MTI’s PolypDx™ diagnostic test to […]

By |June 16th, 2016|TEC Clients|0 Comments

TEC Edmonton’s Early Assistance Positioned Metabolomic Technologies Inc. to Secure Licensing and Distribution Agreement

EDMONTON, AB – May 5, 2016 – TEC Edmonton client and University of Alberta spinoff company Metabolomic Technologies Inc. (MTI) has signed a multi-million dollar licensing and distribution agreement with Atlantic Diagnostic Laboratories, LLC (ADL) for its flagship product, PolypDx™, a urine-based diagnostic test for detection of adenomatous polyps, the precursor to colorectal cancer.

Every year,  […]

By |May 5th, 2016|TEC Clients, University of Alberta|0 Comments